Providing Guidance and Support for all KPNW Research Compliance Activities

Announcements

Next IRB meeting: March 21, 2018

Submissions for review at the March 2018 IRB meeting should be submitted through the electronic IRB system (eIRB) by the end of work on 3/1/2018.

RE: Continuing Review Submissions: It is the Principal Investigator's responsibility to submit a report for continuing review by the submission deadline.

The eIRB sends courtesy reminders to the study team when a continuing review submission is due. Reminders are sent at 90, 60, and 30 days prior to the approval expiration date. These are the only reminders the study team will receive.

Reminders are discontinued after a continuing form has been opened. If you create a continuing review in the eIRB when you receive the 90-day reminder, you will not receive additional reminders at 60 and 30 days.

Your Feedback Requested!

Help the Research Compliance team by completing an anonymous survey about your experience with the Research Compliance Department's customer service. We appreciate your input!

Research Compliance Committee

Welcome Kaiser Permanente Washington!

Group Health is now Kaiser Permanente Washington. The eIRB system has been updated to reflect this change. Remember to search for "Kaiser Permanente Washington IRB" on the picklist when submitting a request for KPNW to rely on the KP Washington IRB for review of a study. All references in new study applications should be to KP Washington.

Study teams should update references to Group Health in the application form with the next submission to modify the study. If the next submission is for contining review, submit a combined modification and continuing review. It is not necessary to submit a study modification solely to make the update.

For existing studies ceded to Group Health, the eIRB automatically updated the name in the External IRB section of the application.

Data or Specimen Sharing Agreements with KP Washington

Please use the full KP DUA, DTA, or MDTA templates when developing new sharing agreements with KP Washington.

eIRB

Designed to enable researchers and IRB reviewers to manage all aspects of the Institutional Review Board (IRB) Administration process.

Contact Research Compliance

Kaiser Permanente identifies financial conflicts of interest (FCOI) and other situations that may give rise to conflicts of interest, and addresses such situations to ensure research decisions made are in the best interests of KP, its research participants, patients, and members. Kaiser Permanente operates in accordance with federal regulations addressing research financial conflicts of interest through our Policy on FCOI in Research.